Proper inference from Simon's two-stage designs
- PMID: 17960777
- PMCID: PMC6047527
- DOI: 10.1002/sim.3123
Proper inference from Simon's two-stage designs
Abstract
Simon's two-stage designs are very popular for phase II clinical trials. A literature review revealed that the inference procedures used with Simon's designs almost always ignore the actual sampling plan used. Reported P-values, point estimates and confidence intervals for the response rate are not usually adjusted for the design's adaptiveness. In addition, we found that the actual sample size for the second stage is often different from that planned. We present here a method for inferences using both the planned and the actual sample sizes. The conventional and the preferred inference procedures usually yield similar P-values and confidence intervals for the response rate. The conventional inference, however, may contradict the result of the corresponding hypothesis testing.
Figures
References
-
- Simon R. Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials. 1989;10(1):1–10. - PubMed
-
- Bryant J, Day R. Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics. 1995;51(4):1372–1383. - PubMed
-
- Conaway MR, Petroni GR. Design for phase II trials allowing for a trade-off between response and toxicity. Biometrics. 1996;52(4):1375–1386. - PubMed
-
- Thall PF, Cheng SC. Optimal two-stage designs for clinical trials based on safety and efficacy. Statistics in Medicine. 2001;20(7):1023–1032. - PubMed
-
- Panageas KS, Smith A, Gönen M, Chapman PB. An optimal two-stage phase II design utilizing complete and partial response information separately. Controlled Clinical Trials. 2002;23(4):367–37. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources